Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wedemeyer

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Der Internist|December 4, 2014
[Treatment of hepatitis C: what is known?]H Wedemeyer
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus - authors' replyB Maasoumy, H Wedemeyer
Journal of Viral Hepatitis|December 23, 2011
Immunosuppression, liver injury and post-transplant HCV recurrenceS Ciesek, H Wedemeyer
Hospital Formulary|October 1, 1990
Concerns of a pediatric hospital's P & T Committee: quality care emphasized over cost considerationsT Reiley, H Wedemeyer
Alimentary Pharmacology & Therapeutics|March 26, 2018
Letter: the role of direct-acting anti-virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus-induced cirrhosis-Authors' replyF Mettke, H Wedemeyer
Minerva Gastroenterologica E Dietologica|May 21, 2010
Chronic hepatitis E in liver transplant recipients: a significant clinical problem?S Pischke, H Wedemeyer
Der Internist|January 15, 2003
[Acute hepatitis C--therapy with interferon alpha-2b]]H Wedemeyer, M P Manns
Der Internist|October 2, 2020
[Acute liver failure-The importance of rapid diagnostics and early initiation of treatment]M Busch, H H Wedemeyer
Scandinavian Journal of Gastroenterology|November 11, 2009
Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirinA Potthoff, T Berg, H Wedemeyer, et al.
MMW Fortschritte Der Medizin|November 28, 2019
M Kleefisch, C Lange, H Wedemeyer
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Der Internist|December 4, 2014
[Treatment of hepatitis C: what is known?]H Wedemeyer
Alimentary Pharmacology & Therapeutics|February 6, 2014
Commentary: detection of low level viraemia in telaprevir-based triple therapy for hepatitis C virus - authors' replyB Maasoumy, H Wedemeyer
Journal of Viral Hepatitis|December 23, 2011
Immunosuppression, liver injury and post-transplant HCV recurrenceS Ciesek, H Wedemeyer
Hospital Formulary|October 1, 1990
Concerns of a pediatric hospital's P & T Committee: quality care emphasized over cost considerationsT Reiley, H Wedemeyer
Alimentary Pharmacology & Therapeutics|March 26, 2018
Letter: the role of direct-acting anti-virals in determining the risk of hepatocellular carcinoma development in patients with hepatitis C virus-induced cirrhosis-Authors' replyF Mettke, H Wedemeyer
Minerva Gastroenterologica E Dietologica|May 21, 2010
Chronic hepatitis E in liver transplant recipients: a significant clinical problem?S Pischke, H Wedemeyer
Der Internist|January 15, 2003
[Acute hepatitis C--therapy with interferon alpha-2b]]H Wedemeyer, M P Manns
Der Internist|October 2, 2020
[Acute liver failure-The importance of rapid diagnostics and early initiation of treatment]M Busch, H H Wedemeyer
Scandinavian Journal of Gastroenterology|November 11, 2009
Late hepatitis B virus relapse in patients co-infected with hepatitis B virus and hepatitis C virus after antiviral treatment with pegylated interferon-a2b and ribavirinA Potthoff, T Berg, H Wedemeyer, et al.
MMW Fortschritte Der Medizin|November 28, 2019
M Kleefisch, C Lange, H Wedemeyer
Pageof 16